SARS-CoV-2 Antibody-based IVIG
SARS-CoV-2 Antibody-based IVIG Uses, Dosage, Side Effects, Food Interaction and all others data.
Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG) is obtained from the plasma of patients who recover from COVID-19 and develop neutralizing antibodies. Anti-coronavirus immunoglobulin is derived from COVID-19 convalescent plasma(https://go.drugbank.com/drugs/DB15692) but contains more SARS-CoV-2 neutralizing antibodies than found in convalescent plasma as the antibodies are highly purified and concentrated.
| Trade Name | SARS-CoV-2 Antibody-based IVIG |
| Generic | Anti-SARS-CoV-2 immunoglobulin |
| Anti-SARS-CoV-2 immunoglobulin Other Names | Anti-Coronavirus immunoglobulin, Anti-COVID-19 hyperimmune globulin (human), GC5131, hIVIG, Human plasma-derived immune-globulin for Coronavirus, Hyperimmune immunoglobulin to SARS-CoV-2, Immune-globulin for Coronavirus disease (COVID-19), SARS-CoV-2 antibody-based IVIG, SARS-CoV-2 immunoglobulin |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here SARS-CoV-2 Antibody-based IVIG
